Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000919574-26-001133·DIALECTIC CAPITAL MANAGEMENT, LP
Schedule 13G ownership disclosure
DiaMedica Therapeutics Inc
Voting common shares, no par value per share · CUSIP: 25253X207
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Dialectic Life Sciences SPV LLC
Shares: 0.00 · Class: 0%
- Dialectic LS Manager LLC
Shares: 0.00 · Class: 0%
- Dialectic Capital Management, LP
Shares: 0.00 · Class: 0%
- Dialectic Partners, LLC
Shares: 0.00 · Class: 0%
- John Fichthorn
Shares: 153,983.00 · Class: 0.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-26-001133
- Form type
- SCHEDULE 13G/A
- Filer
- DIALECTIC CAPITAL MANAGEMENT, LP
- CIK
- CIK 1411512
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership